Guardant Health Director Roberto Mignone Acquires 264 Shares via RSU Vesting
Guardant Health, Inc.
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 4 Filed: Guardant Health, Inc. ($GH) Insider: Roberto Mignone (Director) Transaction Date: September 21, 2026 Type: Acquisition (RSU Conversion - Code M) Shares Transacted: 264 shares @ $0.00 Total Value: $0.00 Direct Holdings Post-Transaction: 10,274 shares Significance: Low (Routine RSU Vesting)
Comprehensive Analysis
Executive Summary
On September 22, 2026, Guardant Health, Inc. ($GH) director Roberto Mignone filed Form 4 reporting the settlement of 264 restricted stock units (RSUs) into Common Stock on September 21, 2026. This transaction reflects scheduled monthly vesting from an RSU award granted in November 2024.
Transaction Breakdown
- Security: Common Stock
- Transaction Code: M (Exercise or conversion of derivative security)
- Shares Acquired: 264
- Price per Share: $0.00
- Total Value: $0.00
- Post-Transaction Beneficial Ownership: 10,274 shares held directly
- Derivative Activity: 264 RSUs converted to common shares, leaving 6,600 unvested RSUs.
Market and Trading Significance
The transaction represents routine equity compensation vesting with no open-market purchase or sale activity. Because this does not involve discretionary buying or selling, it carries low trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.